Choline alfoscerol | Cerepro capsules 400 mg, 28 pcs.

Release form

capsules

Packing

28 pcs.

Indications

acute and recovery periods of severe traumatic brain injury and ischemic stroke, recovery period of hemorrhagic stroke occurring with focal hemispheric symptoms or symptoms of damage to the brain stem

psycho-organic syndrome due to degenerative and involutional changes in the brain

chronic cerebrovascular insufficiency

cognitive disorders (impaired mental function, memory, confusion, disorientation, disorientation, ability to concentrate) including dementia and encephalopathy.

senile pseudomelancholy.

Contraindications

Hypersensitivity, pregnancy, breastfeeding.

Special instructions

If you experience nausea after taking the drug, you should reduce the dose.

Cerepro has no effect on the speed of psychomotor reactions.

Composition

1 caps. choline alfoscerate (glycerylphosphorylcholine hydrate) 400 mg.

Excipients:

glycerol (glycerin),

purified water.

Composition of the capsule shell:

medical gelatin,

glycerol (glycerin),

methyl parahydroxybenzoate (methyl paraben),

propyl parahydroxybenzoate (propyl paraben),

iron dye sorbitol sorbl, srdl, srd

Dosage and administration of

In chronic conditions: 0.4 g orally (1 capsule) 3 times a day, preferably before meals.

Duration of treatment is 3-6 months.

Side effects

Allergic reactions, nausea (due to dopaminergic activation).

Storage conditions

Dry, protected from light and inaccessible to children at a temperature of 25 РC.

active substance

Choline alphosceratus

Conditions of release from drugstores

Prescription

lekarstvennaja form

kapsul

Veropharm, Russia